登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式(希尔记法):
C21H22N2O5S
化学文摘社编号:
分子量:
414.47
UNSPSC Code:
12352209
NACRES:
NA.22
MDL number:
产品名称
Fmoc-Cys(Acm)-OH, Novabiochem®
Quality Level
product line
Novabiochem®
assay
≥96.0% (acidimetric), ≥98% (TLC), ≥99.0% (HPLC)
form
powder
reaction suitability
reaction type: Fmoc solid-phase peptide synthesis
manufacturer/tradename
Novabiochem®
mp
147-150 °C
application(s)
peptide synthesis
functional group
thiol
storage temp.
2-30°C
SMILES string
S(CNC(=O)C)C[C@H](NC(=O)OCC1c2c(cccc2)c3c1cccc3)C(=O)O
InChI
1S/C21H22N2O5S/c1-13(24)22-12-29-11-19(20(25)26)23-21(27)28-10-18-16-8-4-2-6-14(16)15-7-3-5-9-17(15)18/h2-9,18-19H,10-12H2,1H3,(H,22,24)(H,23,27)(H,25,26)/t19-/m0/s1
InChI key
CSMYOORPUGPKAP-IBGZPJMESA-N
General description
The side-chain Acm group is stable to TFA but can be removed with Hg(II) [1] or Ag(I) [2] to give cysteinyl peptides, or oxidatively with Tl(III) [3] or I2 [4] to generate cystinyl peptides.
Associated Protocols and Technical Articles
Cleavage and Deprotection Protocols for Fmoc SPPS
Fmoc SPPS of Cysteine-Containing Peptides
Literature references
[1] D. F. Veber, et al. (1972) J. Am. Chem. Soc., 94, 5456.
[2] M. Yoshida, et al. (1990) Chem. Pharm. Bull., 38, 273.
[3] N. Fujii, et al. (1987) Chem. Pharm. Bull., 36, 2339.
[4] B. Kamber, et al. (1980) Helv. Chim. Acta, 63, 899.
Associated Protocols and Technical Articles
Cleavage and Deprotection Protocols for Fmoc SPPS
Fmoc SPPS of Cysteine-Containing Peptides
Literature references
[1] D. F. Veber, et al. (1972) J. Am. Chem. Soc., 94, 5456.
[2] M. Yoshida, et al. (1990) Chem. Pharm. Bull., 38, 273.
[3] N. Fujii, et al. (1987) Chem. Pharm. Bull., 36, 2339.
[4] B. Kamber, et al. (1980) Helv. Chim. Acta, 63, 899.
Analysis Note
Color (visual): white to slight yellow to beige
Appearance of substance (visual): powder
Identity (IR): passes test
Enantiomeric purity: ≥ 99.5 % (a/a)
Purity (TLC(011B)): ≥ 98 %
Purity (TLC(0811)): ≥ 98 %
Assay (HPLC, area%): ≥ 99.0 % (a/a)
Solubility (25 mmole in 50 ml DMF): clearly soluble
UV/VIS (E(450 bis 600 nm)): ≤ 50 mAU
Assay (acidimetric): ≥ 96.0 %
Water (K. F.): ≤ 5.00 %
To see the solvent systems used for TLC of Novabiochem® products please click here.
Appearance of substance (visual): powder
Identity (IR): passes test
Enantiomeric purity: ≥ 99.5 % (a/a)
Purity (TLC(011B)): ≥ 98 %
Purity (TLC(0811)): ≥ 98 %
Assay (HPLC, area%): ≥ 99.0 % (a/a)
Solubility (25 mmole in 50 ml DMF): clearly soluble
UV/VIS (E(450 bis 600 nm)): ≤ 50 mAU
Assay (acidimetric): ≥ 96.0 %
Water (K. F.): ≤ 5.00 %
To see the solvent systems used for TLC of Novabiochem® products please click here.
Other Notes
Replaces: 04-12-1014
Legal Information
Novabiochem is a registered trademark of Merck KGaA, Darmstadt, Germany
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
实验方案
Overcome challenges in synthesis and disulfide bond formation with protocols for Fmoc solid-phase peptide synthesis of peptides with cysteine and methionine.
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 8520060005 | 04027269084639 |
| 8520060100 | 04027269084653 |
| 8520060025 | 04027269084646 |
